Nanoform Finland Oyj (HEL:NANOFH)

Market Cap	66.57M -34.2%
Revenue (ttm)	3.84M +58.2%
Net Income	-21.77M
EPS	-0.26
Shares Out	85.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	229,591
Average Volume	163,577
Open	0.7840
Previous Close	0.7770
Day's Range	0.7510 - 0.7900
52-Week Range	0.7240 - 1.3820
Beta	0.31
RSI	23.28
Earnings Date	Feb 26, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 173
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: NANOFH

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.